SHARE
COPY LINK

COVID-19 VACCINES

Covid boosters not available in Switzerland until autumn

The Swiss government will not make second Covid boosters available until autumn, saying those who are currently fully vaccinated face a low risk of contracting the virus.

Several vials of Covid vaccine with purple lids
When is Switzerland set for a second booster? Photo: ARIANA DREHSLER / AFP

The Federal Office of Public Health (FOPH) announced on Tuesday that second Covid booster shots for general population will be available in the fall, “when the risk for individuals and the burden on the healthcare system will be greatest”.

While Switzerland had a widespread booster shot campaign against Covid, the government has been reluctant to approve second boosters other than for those in vulnerable categories. 

Right now, those with a weakened immune system and people over the age of 80 are the only ones eligible. 

People not in those risk groups who want a second booster will need to pay out of pocket for the jab. 

This may be people who feel they are in a risk group but are not included in the government’s list, or those who need a booster for travelling abroad. 

People who are travelling to countries where proof of up-to-date immunisation is required but whose Covid certificates are no longer valid, can receive the fourth dose but upon request have to pay for the shot.

Previously, all Covid boosters have been free for Swiss citizens and residents, with the government electing to cover the costs. 

How much will a Covid booster for travel cost? 

While the federal government previously covered the costs of the vaccines, it is now up to individual vaccination centres to set a price for a second booster. 

A spokesperson from the FOPH told The Local on Wednesday that the cost tends to be around CHF60 across much of the country. 

Please keep in mind that this cost only relates to second booster shots for those not in vulnerable categories. For those wanting their first booster – or indeed their first or second shot of the vaccine – the government will continue to cover the costs. 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19 VACCINES

Switzerland to start dual-strain Covid boosters in October

The long-awaited second booster shots will be rolled in Switzerland from October 10th, the Health Ministry announced on Friday.

Switzerland to start dual-strain Covid boosters in October

Less than two weeks after drug regulator Swissmedic approved the new version of the Moderna vaccine, which should better target certain sub-variants of Omicron, the Federal Office of Public Health (FOPH) said on Friday the shots will be available to some groups of the population from October 10th.

“The vaccination recommendation for autumn 2022 aims primarily to protect vulnerable people against a severe form of the disease. On the one hand, people aged 65 or over, and on the other hand, those aged 16 to 64 with an increased risk, for example due to a pre-existing disease or pregnancy”; FOPH said in a statement on Friday.

After that, those “aged 16 to 64, without risk factors and who work in acute and long-term care, or who care for vulnerable people in a professional or private capacity” will be eligible for the shots, FOPH said.Health officials noted that while the number of Covid infection is currently “relatively low, an increase in transmissions of the virus is expected from the fall of 2022. The risk of contracting Covid-19 and the burden for the health system could therefore increase again”.

It added, however, that “the situation differs markedly from that of the last two winters; currently, 97 percent of the population have antibodies against Covid following vaccination or recovery. “People without risk factors are unlikely to develop severe symptoms this fall”.

Dual-strain vaccine

In recent trials, the new Moderna vaccine demonstrated “higher antibody concentrations against the Omicron variants” than the manufacturer’s original Covid vaccine, Swissmedic said.

The previous vaccine was effective against early strains, like Alpha and Delta, offering no immunity against Omicron or its sub-variants, which are currently responsible for all the coronavirus infections detected in Switzerland.

“Compared to the original vaccine, trials have shown that this [vaccine] produces a stronger immune response against the Omicron variants BA.1 and BA.4/5″, Swissmedic said, adding that the new vaccine remains as effective as its predecessor against the original Covid viruses.

Additionally, “a careful review of the application documents submitted on an ongoing basis showed that the vaccine meets the safety, efficacy and quality requirements », the agency noted.

Also, in terms of secondary effects, they are expected to be “similar” to those following administration of the second dose and the first the booster of the original vaccine: fever, muscle pains, and headaches.

According to FOPH, “the bivalent mRNA vaccines, which are tailored to the Omicron BA.1 variant, should be preferred for booster vaccination. However, it is still possible to use the current monovalent mRNA vaccine”.

Additionally, protein-based Nuvaxovid doses will also be available.

READ MORE: BREAKING: Switzerland approves new Covid-19 boosters
 
 

SHOW COMMENTS